0001213900-26-059559.txt : 20260520 0001213900-26-059559.hdr.sgml : 20260520 20260520163022 ACCESSION NUMBER: 0001213900-26-059559 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260514 FILED AS OF DATE: 20260520 DATE AS OF CHANGE: 20260520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Townsend John CENTRAL INDEX KEY: 0001511906 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40582 FILM NUMBER: 261004460 MAIL ADDRESS: STREET 1: 15150 AVENUE OF SCIENCE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Unicycive Therapeutics, Inc. CENTRAL INDEX KEY: 0001766140 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 813638692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1975 W. EL CAMINO REAL, SUITE 204 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94040 BUSINESS PHONE: 650-384-0642 MAIL ADDRESS: STREET 1: 1975 W. EL CAMINO REAL, SUITE 204 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94040 4 1 ownership.xml X0609 4 2026-05-14 0 0001766140 Unicycive Therapeutics, Inc. UNCY 0001511906 Townsend John false C/O UNICYCIVE THERAPEUTICS, INC. 1975 W. EL CAMINO REAL, SUITE 204 MOUNTAIN VIEW CA 94040 0 1 0 0 CFO 0 Restricted Stock Unit 0 2026-05-14 4 A 0 169500 0 A Common Stock 169500 169500 D Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award vest 1/3 on the anniversary of the grant date for 3 years, subject to the Reporting Person's continued service with the Issuer. /s/ John Townsend 2026-05-20